Groups urge tobacco legislation
This article was originally published in The Tan Sheet
Executive Summary
A report released Feb. 20 by a coalition of public health organizations says that the current lack of government regulation gives the tobacco industry "free reign" to target children, mislead consumers and discourage smokers from quitting. Specifically, the study says flavored products, such as cigarettes flavored like candy, fruit and alcohol "mask the harshness of the products" making them "more appealing to children." In an effort to snuff sales of this "insidious new generation of tobacco products," Sen. Richard Durbin, D-Ill., joined the coalition in issuing the report, promoting legislation that would give FDA authority to regulate tobacco products and their marketing. Durbin introduced S.625 and Rep. Henry Waxman introduced H.R. 1108 early last year to empower FDA to ban candy-flavored cigarettes, require companies to disclose ingredients in tobacco products, require removal of harmful ingredients and prohibit claims such as "reduced risk," "low-tar," "light" and "mild"...
You may also be interested in...
FDA authority over tobacco?
The House Energy and Commerce Committee April 3 approved a bill, H.R. 1108, that would give FDA authority to regulate tobacco, although the legislation would prevent the agency from banning cigarettes altogether or from requiring nicotine-free products. Under the bill introduced by Rep. Henry Waxman, D-Calif., industry user fees would fund FDA's tobacco regulation, including establishing an oversight office. The legislation would allow FDA to monitor cigarette labeling, ban flavored cigarettes and limit advertisements making claims that one product is safer than another (1"The Tan Sheet" Feb. 25, 2008, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.